Stay updated with breaking news from Nasdaq Pyxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abrdn plc acquired a new position in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,303 shares of the company’s stock, valued at approximately $1,275,000. Several other large investors have also recently modified their […]
Royal Bank of Canada reiterated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research note released on Friday morning, Benzinga reports. The firm currently has a $7.00 price objective on the stock. PYXS has been the topic of several other reports. Leerink Partnrs reissued an outperform rating on shares […]
Pyxis Oncology (NASDAQ:PYXS – Free Report) had its price target upped by HC Wainwright from $4.00 to $7.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other equities research analysts have also issued reports about the company. BTIG Research began coverage […]
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has earned an average rating of “Buy” from the eight research firms that are presently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the […]
SVB Leerink started coverage on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a report issued on Tuesday, Marketbeat.com reports. The firm issued an outperform rating and a $12.00 target price on the stock. A number of other brokerages have also recently weighed in on PYXS. HC Wainwright reissued a buy rating and issued […]